Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,185 shares at $293.83 ($1.5M) on 2023-02-21, disclosed to the SEC on 2023-02-22.
Seasonal sale ($1.5M) by EVP, Chief Reg. & Quality Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $292.85 | 4,498 | $1.3M | 86.7% |
| 2 | $291.01 | 4 | $1K | 0.1% |
| 3 | $292.85 | 145 | $42K | 2.8% |
| 4 | $293.83 | 207 | $61K | 4.0% |
| 5 | $293.83 | 207 | $61K | 4.0% |
| 6 | $294.77 | 124 |
| $37K |
| 2.4% |
| Total | $292.97 avg | 5,185 | $1.5M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |